Equities

Zylox-Tonbridge Medical Technology Co Ltd

Zylox-Tonbridge Medical Technology Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (HKD)11.06
  • Today's Change0.06 / 0.55%
  • Shares traded210.50k
  • 1 Year change0.00%
  • Beta0.9314
Data delayed at least 15 minutes, as of Nov 22 2024 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Zylox-Tonbridge Medical Technology Co Ltd, formerly Zylox Medical Device Co Ltd, is a China-based company mainly engaged in the research and development of neurological and peripheral vascular interventional medical devices. The Company's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). The Company's products are sold to domestic and foreign markets.

  • Revenue in HKD (TTM)712.85m
  • Net income in HKD27.55m
  • Incorporated2012
  • Employees756.00
  • Location
    Zylox-Tonbridge Medical Technology Co Ltd270 Shuyun RoadCangqian Street, Yuhang DistrictHANGZHOU ChinaCHN
  • Phone+86 57 188610082
  • Fax+86 57 188610608
  • Websitehttps://www.zyloxtb.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
MicroTech Medical Hangzhou Co Ltd314.99m-154.78m1.86bn750.00--0.8705--5.90-0.3651-0.36510.74565.08------414,453.90--------51.01---49.14--12.74--0.01--45.86---256.75------
Acotec Scientific Holdings Ltd561.94m34.45m2.28bn615.0063.741.5925.874.070.11440.11441.874.580.31580.83923.96880,778.201.94--2.11--76.37--6.13--6.10--0.1626--19.80---79.35------
Venus MedTech HangZhou Inc501.09m-601.61m2.48bn778.00--0.8466--4.95-1.37-1.371.146.640.10490.80141.38579,298.40-12.85-13.20-14.73-14.9779.2679.51-122.55-152.831.97-11.190.1547--20.8933.6233.46--58.20--
Peijia Medical Ltd555.85m-270.41m2.58bn1.05k--1.12--4.64-0.3973-0.39730.81713.450.19020.89969.90534,471.30-9.25-34.08-9.85-36.9071.7571.62-48.65-448.756.11--0.1038--75.86--3.75--106.68--
IVD Medical Holding Ltd3.29bn279.77m2.89bn815.008.600.66148.990.87890.20690.20692.442.690.62022.186.954,099,518.005.285.187.446.6722.6720.758.517.531.287.490.1926--12.3549.4913.4118.1519.77--
Modern Dental Group Ltd3.27bn408.15m3.36bn7.18k8.271.246.141.030.4290.4293.442.850.84719.385.14465,149.5010.527.0512.358.3453.4050.7712.419.242.5810.750.240539.9812.086.5083.3036.462.42--
OrbusNeich Medical Group Holdings Ltd1.18bn301.36m3.45bn1.28k11.501.1910.182.930.36270.36271.423.500.38391.154.20943,274.209.83--10.63--68.71--25.61--8.32--0.0214--12.45--143.76------
China Isotope & Radiation Corp7.20bn428.14m3.51bn3.13k8.200.68913.160.48771.341.3422.5215.930.5253.371.802,319,527.006.266.5712.8513.2651.6359.8911.9212.621.6757.070.218728.277.8215.35-5.432.883.632.89
Zylox-Tonbridge Medical Technolgy Co Ltd712.85m27.55m3.60bn756.00130.751.0755.625.060.08410.08412.1810.290.19571.16473.84931,828.600.7561--0.8234--71.62--3.86--3.38--0.0255--57.97--30.66------
Shanghai INT Medical Instruments Co Ltd865.15m189.59m4.95bn1.73k24.972.7419.135.721.131.135.1110.250.41282.0812.01552,105.408.818.6310.419.7660.1659.4421.3426.162.06--0.038431.8028.5029.9618.7921.7645.75--
Data as of Nov 22 2024. Currency figures normalised to Zylox-Tonbridge Medical Technology Co Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

24.64%Per cent of shares held by top holders
HolderShares% Held
Lake Bleu Capital (Hong Kong) Ltd.as of 30 Jun 202318.05m5.60%
AIHC Capital Management Ltd.as of 02 Jul 202416.35m5.07%
Snow Lake Management LPas of 17 Feb 202316.20m5.03%
Schroder Investment Management (Hong Kong) Ltd.as of 17 Oct 202414.16m4.39%
Fidelity Management & Research (Hong Kong) Ltd.as of 30 Sep 20246.46m2.00%
FIL Investment Management (Hong Kong) Ltd.as of 31 Jul 20241.93m0.60%
Schroder Investment Management (Singapore) Ltd.as of 17 Oct 20241.78m0.55%
Mediolanum International Funds Ltd.as of 28 Jun 20241.75m0.54%
E Fund Management Co., Ltd.as of 30 Jun 20241.59m0.49%
Fidelity Management & Research Co. LLCas of 30 Sep 20241.17m0.36%
More ▼
Data from 28 Sep 2023 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.